Revenue | $10 - $100 million See Exact Annual Revenue |
---|---|
Employees | 10 - 100Exact Company Size |
Primary Industry | 5416 Management, Scientific & Technical Consulting Services |
Address | 5353 Wayzata Blvd, #505 Minneapolis, MN 55416 |
Regulatory & Clinical Research Institute | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
---|---|---|---|
2023 | $10 - $100 million Details in Premium Report | ||
2022 | |||
2021 | |||
2020 | |||
2019 |
1-Year Growth Rate: 3-Year Growth Rate (CAGR): | ![]() |
Regulatory & Clinical Research Institute P&L | $ Millions |
---|---|
Revenue (Sales) | ![]() |
Cost of Goods Sold | |
Gross Profit | |
Operating Expenses | |
Advertising | |
Salaries and wages | |
Other Operating Expenses | |
Total Operating Expenses | |
Operating Income | |
EBITDA | |
EBIT (Earnings Before Interest and Taxes) | |
Net Profit | |
Trademark | Date |
---|---|
EXPERT ADVISORS. EXACT PRACTICES. Identification of regulatory strategies for product market applications and reimbursement; preparation and submission of product applications to the FDA and other regulatory agencies; preparing business reports for governmental agencies and medical journals resulting from clinical studies; providing reimbursement and health economic services, namely, researching and analyzing current reimbursement policies, product and procedure codes and pricing; providing due diligence services, namely, evaluating regulatory strategies, clinical strategies, product reimbursement strategies and quality systems on behalf of venture capitalists | 11/09/2012 |
FROM CONCEPT TO MARKET Identification of regulatory strategies for product market applications and reimbursement; preparation and submission of product applications to the FDA and other regulatory agencies; preparing business reports for governmental agencies and medical journals resulting from clinical studies; providing reimbursement and health economic services, namely, researching and analyzing current reimbursement policies, product and procedure codes and pricing; providing due diligence services, namely, evaluating regulatory strategies, clinical strategies, product reimbursement strategies and quality systems on behalf of venture capitalists | 02/24/2005 |
RCRI Providing financial due diligence services, namely, assessing and evaluating clinical, regulatory and reimbursement strategies for venture capitalists | 02/23/2005 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
LCP HAMPTON BEACH HOSPITALITY | Plymouth, MA | 100 |
BOOZ ALLEN HAMILTON | Mclean, VA | 16 |
ACCENTURE | Chicago, IL | 14 |
MCKINSEY | New York, NY | 12 |
DELAWARE NORTH COMPANIES | Buffalo, NY | 6 |
ATLAS TECHNOLOGY SOLUTIONS | Chicago, IL | 5 |
MAXIMUS SERVICES | Mclean, VA | 5 |
WILLIS TOWERS WATSON US | Arlington, VA | 4 |
KBR HOLDINGS | Houston, TX | 3 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
3BRIDGE SOLUTIONS | Minneapolis, MN | 100 |
OVATIVE GROUP | Minneapolis, MN | 64 |
PHDATA | Minneapolis, MN | 31 |
COSMOPOLITAN & ASSOCIATES | Minneapolis, MN | 24 |
MERJENT | Minneapolis, MN | 23 |
CLARITAS | Minneapolis, MN | 19 |
Company | Revenue ($ MM) |
---|---|
![]() |